Suppressive Functions of Regulatory T Cells in Migraine

NCT ID
NCT07067112
Registry status
Recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
University Hospital, Clermont-Ferrand
Conditions
Chronic Migraine

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 24 participants (Estimated).

What is being studied

  • Biological: Blood sampling, questionnaire and phone call
  • Intervention: Blood Specimen Collection
  • Intervention: Clinical Laboratory Techniques
  • Intervention: Data Collection
  • Intervention: Diagnosis
  • Intervention: Diagnostic Techniques and Procedures
  • Intervention: Environment and Public Health
  • Intervention: Epidemiologic Methods
  • Intervention: Health Care Evaluation Mechanisms
  • Intervention: Health Care Quality, Access, and Evaluation
  • Intervention: Investigative Techniques
  • Intervention: Public Health
  • Intervention: Punctures
  • Intervention: Quality of Health Care
  • Intervention: Specimen Handling
  • Intervention: Surgical Procedures, Operative
  • Intervention: Surveys and Questionnaires

Who may be eligible

Ages
18 Years to 50 Years
Sex
Female
Healthy volunteers accepted
Yes

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Females * 18 to 50 years old * For chronic migrain : At least 8 monthly migraine days Exclusion Criteria: * BMI \< or = 17kg/m² or \> or = 30kg/m² * Diagnosis or suspicion of type 2 diabetes, auto-immune or inflammatory diseases, immunodeficiency diseases * Diagnosis of headache of non-migraine origin, except for tension type headache (i.e.: cluster headache, post-traumatic headache, cerebral tumour…) * For controls participants : tension type headache with 4 or more monthly headache days * Pregnancy, delivery, miscarriage, breastfeeding, participation in a medically assisted human reproduction program (ovary stimulation/hormone therapy) \< 3 months before blood sampling * Menopause, hysterectomy, or bilateral oophorectomy * Modification of prophylactic anti-migraine therapy (start, change of molecule, interruption) \< 1 month before blood sampling (for migraine participants) * Hormone therapy (beside contraception and treatment of endometriosis) * Transplantation (solid organ or bone marrow) * Cancer (active or remitting) \< 1 year before blood sampling (solid organ or blood) * Haematologic disease (benign or malignant) of the lymphoid lineage * Guardianship, curatorship, safeguard of justice or deprivation of liberty * For controls : history of migraine

Study locations

1 study location is listed.

Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.

Countries: France

Sample of listed locations

  • CHU Clermont-Ferrand — Clermont-Ferrand, France — Recruiting

Study details

Start date
September 10, 2026
Primary completion date
November 30, 2027
Completion date
November 30, 2027
First posted
July 16, 2025

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07067112
Registry last updated
October 14, 2026
QualifiedStudies registry data refreshed
October 19, 2026
QualifiedStudies record fetched
October 19, 2026

View NCT07067112 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Migraines studies | Clinical trial FAQ